Sustainable access models to healthcare need a bold mindset shift, says Boehringer Ingelheim GM

The growing complexities in the delivery of equitable and timely healthcare is forcing leaders to challenge their conventional methods.

Dirk Otto, General Manager and Head of Human Pharma, Boehringer Ingelheim ANZ joined Health Industry Hub in his first media interview since commencing his local leadership role in June 2022.

COVID-19 has been a catalyst for leadership change. Leaders need to bridge the gap between perform and transform and unite employees behind a common purpose with empathy and compassion. Dirk reflected on his leadership style and the key highlights of his observations at the local affiliate over the past few months.

He talked of the complex challenges facing the Australian healthcare system and the company’s three-pillar approach to increase equitable and timely access to healthcare. He put forward his perspectives on how to engage in a holistic view of the patient journey and the entire stakeholder ecosystem to bring forth sustainable access models.

As we head into the new year, Dirk contemplated the trends that make him optimistic about the future of the pharma industry and BI’s contribution in bringing precision medicine and personalised healthcare to more patients.

Reimagining healthcare across the entire patient journey: Health Industry Hub^TM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change in healthcare.

The content on Health Industry Hub is copyright protected and can only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.